Palatin Technologies Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Palatin Technologies Inc.

Palatin Technologies Inc. | Key People and Executives

Carl Spana

President, Chief Executive Officer & Director

John K. A. Prendergast

Chairman

Arlene M. Morris

Independent Director

Anthony M. Manning

Independent Director

Angela Rossetti

Independent Director

Alan W. Dunton

Independent Director

Joseph Stanley Hull

Independent Director

Robert K. deVeer

Independent Director

Carl Spana

President, Chief Executive Officer & Director

Stephen T. Wills

COO, CFO, Secretary, Treasurer & Executive VP

Johna Lucas

Chief Medical Officer

John K. A. Prendergast

Chairman

Arlene M. Morris

Independent Director

Anthony M. Manning

Independent Director

Angela Rossetti

Independent Director

Alan W. Dunton

Independent Director

Joseph Stanley Hull

Independent Director

Robert K. deVeer

Independent Director

View Profile

Address	Cedar Brook Corporate Center Cranbury New Jersey 08512 United States
Employees	-
Website	http://www.palatin.com
Updated	07/08/2019
Palatin Technologies, Inc. is a biopharmaceutical company which develops targeted, receptor-specific peptide therapeutics for the treatment of diseases. It specializes in molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. It offers product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder, which is a type of female sexual dysfunction, defined as low desire with associated distress.